PPD’s Evidera expands patient-centered research services
Evidera has expanded its patient-centered research services, the advancement of which will enable the introduction of better treatments, faster, says team VP.
Evidera has expanded its patient-centered research services, the advancement of which will enable the introduction of better treatments, faster, says team VP.
Clinigen Group plc has acquired the Japanese unlicensed medicines supplier International Medical Management Corporation (IMMC) in order to further develop its market access, says CEO.
The validation services company has created a Rapid Response Team to address pharmaceutical product regulatory and compliance citations.
CPhI Worldwide 2017
The pharma world has converged in Frankfurt, Germany for this year’s CPhI Worldwide. In-Pharmatechnologist is here too to report the latest trends affecting the industry.
news in brief
Safic-Alcan has partnered with Turkish API, excipients and chemical distributor Marmara Ecza to expand its presence in the country.
Chiome Bioscience has selected ProBioGen to develop and manufacture its monoclonal antibody LIV-1205, which is designed to combat liver cancer and solid tumours.
Sterling Pharma Solutions has announced a £6m ($8m) investment in solid form capabilities at its Dudley, UK-based site.